List of Tables
Table 1. Major Company of 99% Purity
Table 2. Major Company of 98% Purity
Table 3. Major Company of Other
Table 4. Global Imatinib Mesylate Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Imatinib Mesylate Sales by Type (2018-2023) & (MT)
Table 6. Global Imatinib Mesylate Sales Market Share in Volume by Type (2018-2023)
Table 7. Global Imatinib Mesylate Sales by Type (2018-2023) & (US& Million)
Table 8. Global Imatinib Mesylate Market Share in Value by Type (2018-2023)
Table 9. Global Imatinib Mesylate Price by Type (2018-2023) & (USD/MT)
Table 10. Global Imatinib Mesylate Sales by Type (2024-2029) & (MT)
Table 11. Global Imatinib Mesylate Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Imatinib Mesylate Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Imatinib Mesylate Sales Market Share in Value by Type (2024-2029)
Table 14. Global Imatinib Mesylate Price by Type (2024-2029) & (USD/MT)
Table 15. North America Imatinib Mesylate Sales by Type (2018-2023) & (MT)
Table 16. North America Imatinib Mesylate Sales by Type (2018-2023) & (US$ Million)
Table 17. Europe Imatinib Mesylate Sales (MT) by Type (2018-2023)
Table 18. Europe Imatinib Mesylate Sales by Type (2018-2023) & (US$ Million)
Table 19. Asia-Pacific Imatinib Mesylate Sales (MT) by Type (2018-2023)
Table 20. Asia-Pacific Imatinib Mesylate Sales by Type (2018-2023) & (US$ Million)
Table 21. Latin America Imatinib Mesylate Sales (MT) by Type (2018-2023)
Table 22. Latin America Imatinib Mesylate Sales by Type (2018-2023) & (US$ Million)
Table 23. Middle East and Africa Imatinib Mesylate Sales (MT) by Type (2018-2023)
Table 24. Middle East and Africa Imatinib Mesylate Sales by Type (2018-2023) & (US$ Million)
Table 25. Global Imatinib Mesylate Sales by Company (2018-2023) & (MT)
Table 26. Global Imatinib Mesylate Sales Share by Company (2018-2023)
Table 27. Global Imatinib Mesylate Revenue by Company (2018-2023) & (US$ Million)
Table 28. Global Imatinib Mesylate Revenue Share by Company (2018-2023)
Table 29. Global Market Imatinib Mesylate Price by Company (2018-2023) & (USD/MT)
Table 30. Global Imatinib Mesylate Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Imatinib Mesylate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Imatinib Mesylate as of 2022)
Table 33. Date of Key Manufacturers Enter into Imatinib Mesylate Market
Table 34. Key Manufacturers Imatinib Mesylate Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Imatinib Mesylate Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Imatinib Mesylate Sales by Region (2018-2023) & (MT)
Table 38. Global Imatinib Mesylate Sales Market Share in Volume by Region (2018-2023)
Table 39. Global Imatinib Mesylate Sales by Region (2018-2023) & (US$ Million)
Table 40. Global Imatinib Mesylate Sales Market Share in Value by Region (2018-2023)
Table 41. Global Imatinib Mesylate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 42. Global Imatinib Mesylate Sales by Region (2024-2029) & (MT)
Table 43. Global Imatinib Mesylate Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Imatinib Mesylate Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Imatinib Mesylate Sales Market Share in Value by Region (2024-2029)
Table 46. Global Imatinib Mesylate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2029)
Table 47. Global Imatinib Mesylate Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Imatinib Mesylate Sales by Application (2018-2023) & (MT)
Table 49. Global Imatinib Mesylate Sales Market Share in Volume by Application (2018-2023)
Table 50. Global Imatinib Mesylate Sales by Application (2018-2023) & (US$ Million)
Table 51. Global Imatinib Mesylate Sales Market Share in Value by Application (2018-2023)
Table 52. Global Imatinib Mesylate Price by Application (2018-2023) & (USD/MT)
Table 53. Global Imatinib Mesylate Sales by Application (2024-2029) & (MT)
Table 54. Global Imatinib Mesylate Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Imatinib Mesylate Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Imatinib Mesylate Sales Market Share in Value by Application (2024-2029)
Table 57. Global Imatinib Mesylate Price by Application (2024-2029) & (USD/MT)
Table 58. North America Imatinib Mesylate Sales by Application (2018-2023) (MT)
Table 59. North America Imatinib Mesylate Sales by Application (2018-2023) & (US$ Million)
Table 60. Europe Imatinib Mesylate Sales by Application (2018-2023) (MT)
Table 61. Europe Imatinib Mesylate Sales by Application (2018-2023) & (US$ Million)
Table 62. Asia-Pacific Imatinib Mesylate Sales by Application (2018-2023) (MT)
Table 63. Asia-Pacific Imatinib Mesylate Sales by Application (2018-2023) & (US$ Million)
Table 64. Latin America Imatinib Mesylate Sales by Application (2018-2023) (MT)
Table 65. Latin America Imatinib Mesylate Sales by Application (2018-2023) & (US$ Million)
Table 66. Middle East and Africa Imatinib Mesylate Sales by Application (2018-2023) (MT)
Table 67. Middle East and Africa Imatinib Mesylate Sales by Application (2018-2023) & (US$ Million)
Table 68. North America Imatinib Mesylate Sales by Country (2018-2023) & (MT)
Table 69. North America Imatinib Mesylate Sales Market Share in Volume by Country (2018-2023)
Table 70. North America Imatinib Mesylate Sales by Country (2018-2023) & (US$ Million)
Table 71. North America Imatinib Mesylate Sales Market Share in Value by Country (2018-2023)
Table 72. North America Imatinib Mesylate Sales by Country (2024-2029) & (MT)
Table 73. North America Imatinib Mesylate Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Imatinib Mesylate Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Imatinib Mesylate Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Imatinib Mesylate Sales by Country (2018-2023) & (MT)
Table 77. Europe Imatinib Mesylate Sales Market Share in Volume by Country (2018-2023)
Table 78. Europe Imatinib Mesylate Sales by Country (2018-2023) & (US$ Million)
Table 79. Europe Imatinib Mesylate Sales Market Share in Value by Country (2018-2023)
Table 80. Europe Imatinib Mesylate Sales by Country (2024-2029) & (MT)
Table 81. Europe Imatinib Mesylate Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Imatinib Mesylate Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Imatinib Mesylate Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Imatinib Mesylate Sales by Region (2018-2023) & (MT)
Table 85. Asia-Pacific Imatinib Mesylate Sales Market Share in Volume by Region (2018-2023)
Table 86. Asia-Pacific Imatinib Mesylate Sales by Region (2018-2023) & (US$ Million)
Table 87. Asia-Pacific Imatinib Mesylate Sales Market Share in Value by Region (2018-2023)
Table 88. Asia-Pacific Imatinib Mesylate Sales by Region (2024-2029) & (MT)
Table 89. Asia-Pacific Imatinib Mesylate Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Imatinib Mesylate Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Imatinib Mesylate Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Imatinib Mesylate Sales by Country (2018-2023) & (MT)
Table 93. Latin America Imatinib Mesylate Sales Market Share in Volume by Country (2018-2023)
Table 94. Latin America Imatinib Mesylate Sales by Country (2018-2023) & (US$ Million)
Table 95. Latin America Imatinib Mesylate Sales Market Share in Value by Country (2018-2023)
Table 96. Latin America Imatinib Mesylate Sales by Country (2024-2029) & (MT)
Table 97. Latin America Imatinib Mesylate Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Imatinib Mesylate Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Imatinib Mesylate Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Imatinib Mesylate Sales by Country (2018-2023) & (MT)
Table 101. Middle East and Africa Imatinib Mesylate Sales Market Share in Volume by Country (2018-2023)
Table 102. Middle East and Africa Imatinib Mesylate Sales by Country (2018-2023) & (US$ Million)
Table 103. Middle East and Africa Imatinib Mesylate Sales Market Share in Value by Country (2018-2023)
Table 104. Middle East and Africa Imatinib Mesylate Sales by Country (2024-2029) & (MT)
Table 105. Middle East and Africa Imatinib Mesylate Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Imatinib Mesylate Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Imatinib Mesylate Sales Market Share in Value by Country (2024-2029)
Table 108. GLEEVEC Company Information
Table 109. GLEEVEC Introduction and Business Overview
Table 110. GLEEVEC Imatinib Mesylate Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 111. GLEEVEC Imatinib Mesylate Product
Table 112. GLEEVEC Recent Development
Table 113. Cayman Chemical Company Information
Table 114. Cayman Chemical Introduction and Business Overview
Table 115. Cayman Chemical Imatinib Mesylate Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 116. Cayman Chemical Imatinib Mesylate Product
Table 117. Cayman Chemical Recent Development
Table 118. Sichuan Xieli Company Information
Table 119. Sichuan Xieli Introduction and Business Overview
Table 120. Sichuan Xieli Imatinib Mesylate Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 121. Sichuan Xieli Imatinib Mesylate Product
Table 122. Sichuan Xieli Recent Development
Table 123. Nanjing Kaihua Chemical Company Information
Table 124. Nanjing Kaihua Chemical Introduction and Business Overview
Table 125. Nanjing Kaihua Chemical Imatinib Mesylate Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 126. Nanjing Kaihua Chemical Imatinib Mesylate Product
Table 127. Nanjing Kaihua Chemical Recent Development
Table 128. Zhengda Tianqing Company Information
Table 129. Zhengda Tianqing Introduction and Business Overview
Table 130. Zhengda Tianqing Imatinib Mesylate Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 131. Zhengda Tianqing Imatinib Mesylate Product
Table 132. Zhengda Tianqing Recent Development
Table 133. Key Raw Materials Lists
Table 134. Raw Materials Key Suppliers Lists
Table 135. Imatinib Mesylate Market Trends
Table 136. Imatinib Mesylate Market Drivers
Table 137. Imatinib Mesylate Market Challenges
Table 138. Imatinib Mesylate Market Restraints
Table 139. Imatinib Mesylate Distributors List
Table 140. Imatinib Mesylate Downstream Customers
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Imatinib Mesylate Product Picture
Figure 2. Global Imatinib Mesylate Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Imatinib Mesylate Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Imatinib Mesylate Sales Status and Outlook (2018-2029) & (MT)
Figure 5. Product Picture of 99% Purity
Figure 6. Global 99% Purity Sales YoY Growth (2018-2029) & (MT)
Figure 7. Product Picture of 98% Purity
Figure 8. Global 98% Purity Sales YoY Growth (2018-2029) & (MT)
Figure 9. Product Picture of Other
Figure 10. Global Other Sales YoY Growth (2018-2029) & (MT)
Figure 11. Global Imatinib Mesylate Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Imatinib Mesylate Sales Market Share by Type in 2022 & 2029
Figure 13. North America Imatinib Mesylate Sales Market Share in Volume by Type in 2022
Figure 14. North America Imatinib Mesylate Sales Market Share in Value by Type in 2022
Figure 15. Europe Imatinib Mesylate Sales Market Share in Volume by Type in 2022
Figure 16. Europe Imatinib Mesylate Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Imatinib Mesylate Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Imatinib Mesylate Sales Market Share in Value by Type in 2022
Figure 19. Latin America Imatinib Mesylate Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Imatinib Mesylate Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Imatinib Mesylate Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Imatinib Mesylate Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Imatinib Mesylate Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Imatinib Mesylate Revenue in 2022
Figure 25. Imatinib Mesylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of CML
Figure 27. Global CML Sales YoY Growth (2018-2029) & (MT)
Figure 28. Product Picture of GIST
Figure 29. Global GIST Sales YoY Growth (2018-2029) & (MT)
Figure 30. Product Picture of Other
Figure 31. Global Other Sales YoY Growth (2018-2029) & (MT)
Figure 32. Global Imatinib Mesylate Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Imatinib Mesylate Sales Market Share by Application in 2022 & 2029
Figure 34. North America Imatinib Mesylate Sales Market Share in Volume by Application in 2022
Figure 35. North America Imatinib Mesylate Sales Market Share in Value by Application in 2022
Figure 36. Europe Imatinib Mesylate Sales Market Share in Volume by Application in 2022
Figure 37. Europe Imatinib Mesylate Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Imatinib Mesylate Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Imatinib Mesylate Sales Market Share in Value by Application in 2022
Figure 40. Latin America Imatinib Mesylate Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Imatinib Mesylate Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Imatinib Mesylate Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Imatinib Mesylate Manufacturing Cost Structure
Figure 45. Imatinib Mesylate Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed